Mutilan 125.0 mg/ml Perorální roztok Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

mutilan 125.0 mg/ml perorální roztok

laboratorios karizoo, s.a. - tiamulin - perorální roztok - 125.0mg/ml - pleuromutilin - prasata, kur domácí, krůty

Imlygic Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

imlygic

amgen europe b.v. - talimogene laherparepvec - melanom - antineoplastická činidla - imlygic je indikován k léčbě dospělých pacientů s neresekovatelným melanomem, která je regionálně nebo vzdáleně metastatickým (stadium iiib, iiic a ivm1a) s bez kostí, mozku, plic nebo jiných viscerální onemocnění.

Jayempi Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - odmítnutí štěpu - imunosupresiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Abecma Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastická činidla - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Cylanic 500+125 mg Tableta Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

cylanic 500+125 mg tableta

livisto int'l, s.l. - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory

Cylanic 50+12,5 mg Tableta Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

cylanic 50+12,5 mg tableta

livisto int'l, s.l. - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory - psi, kočky

Cylanic 250+62,5 mg Tableta Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

cylanic 250+62,5 mg tableta

livisto int'l, s.l. - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory - psi, kočky

Clavusan 50+12,5 mg Tableta Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

clavusan 50+12,5 mg tableta

alfasan nederland bv - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory - psi, kočky

Clavusan 250+62,5 mg Tableta Jamhuri ya Cheki - Kicheki - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

clavusan 250+62,5 mg tableta

alfasan nederland bv - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory - psi, kočky